GB Patent

GB2507104A — Electronic inhalation device

Assigned to Nicoventures Holdings Ltd · Expires 2014-04-23 · 12y expired

What this patent protects

An electronic inhalation device comprises a mouthpiece 2 and a control unit 24, the control unit 24 comprising a power cell 22 and a computer 20, where the computer 20 comprises a computer processor, a memory and an input-output means; wherein the device further comprises a trans…

USPTO Abstract

An electronic inhalation device comprises a mouthpiece 2 and a control unit 24, the control unit 24 comprising a power cell 22 and a computer 20, where the computer 20 comprises a computer processor, a memory and an input-output means; wherein the device further comprises a transmitter 18 connected to the computer 20 and the computer is configured in use to collect and store use data relating to a user's use of the device in the computer memory and transmit the use data. Preferably, the use data is transmitted wirelessly to a receiver, which may be provided on a smart phone for example. The transmitter preferably comprises audio signalling means and transmits the use data by sound. The receiver may then be provided as a microphone which picks up the sound signal, preferably transmitted at a frequency to avoid background noise.

Drugs covered by this patent

Patent Metadata

Patent number
GB2507104A
Jurisdiction
GB
Classification
Expires
2014-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Nicoventures Holdings Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.